These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39394056)

  • 1. Association of periodontal disease with the prognosis of chronic kidney disease: A meta-analysis.
    He T; Li X; Liao CJ; Feng XY; Guo XY
    J Chin Med Assoc; 2024 Oct; ():. PubMed ID: 39394056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal disease and subsequent risk of cardiovascular outcome and all-cause mortality: A meta-analysis of prospective studies.
    Guo X; Li X; Liao C; Feng X; He T
    PLoS One; 2023; 18(9):e0290545. PubMed ID: 37682950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors, prevalence and prognostic role of pulmonary hypertension in patients with chronic kidney disease: a systematic review and meta-analysis.
    Lin C; Ge Q; Wang L; Zeng P; Huang M; Li D
    Ren Fail; 2024 Dec; 46(2):2368082. PubMed ID: 38938193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between periodontal disease and mortality in people with CKD: a meta-analysis of cohort studies.
    Zhang J; Jiang H; Sun M; Chen J
    BMC Nephrol; 2017 Aug; 18(1):269. PubMed ID: 28814274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for heart failure in people with chronic kidney disease.
    Lunney M; Ruospo M; Natale P; Quinn RR; Ronksley PE; Konstantinidis I; Palmer SC; Tonelli M; Strippoli GF; Ravani P
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012466. PubMed ID: 32103487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Chronic Kidney Disease on the Prognosis of Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis: A Meta-Analysis of 133624 Patients.
    Wang J; Liu S; Han X; Chen Y; Chen H; Dong S; Song B
    Ann Thorac Cardiovasc Surg; 2022 Apr; 28(2):83-95. PubMed ID: 34897184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.
    Tang M; Batty JA; Lin C; Fan X; Chan KE; Kalim S
    Am J Kidney Dis; 2018 Jul; 72(1):75-83. PubMed ID: 29429751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone antagonists for people with chronic kidney disease requiring dialysis.
    Hasegawa T; Nishiwaki H; Ota E; Levack WM; Noma H
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013109. PubMed ID: 33586138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between periodontitis and chronic kidney disease: Systematic review and meta-analysis.
    Deschamps-Lenhardt S; Martin-Cabezas R; Hannedouche T; Huck O
    Oral Dis; 2019 Mar; 25(2):385-402. PubMed ID: 29377446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.
    Natale P; Tunnicliffe DJ; Toyama T; Palmer SC; Saglimbene VM; Ruospo M; Gargano L; Stallone G; Gesualdo L; Strippoli GF
    Cochrane Database Syst Rev; 2024 May; 5(5):CD015588. PubMed ID: 38770818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urgent-start peritoneal dialysis versus conventional-start peritoneal dialysis for people with chronic kidney disease.
    Htay H; Johnson DW; Craig JC; Teixeira-Pinto A; Hawley CM; Cho Y
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012913. PubMed ID: 33320346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants for chronic kidney disease.
    Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster AC; Perkovic V
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008176. PubMed ID: 23076940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between periodontal disease and the risk of myocardial infarction: a pooled analysis of observational studies.
    Xu S; Song M; Xiong Y; Liu X; He Y; Qin Z
    BMC Cardiovasc Disord; 2017 Feb; 17(1):50. PubMed ID: 28143450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between platelet-lymphocyte ratio and the risk of all-cause mortality in chronic kidney disease: a systematic review and meta-analysis.
    Gan W; Guan Q; Hu X; Zeng X; Shao D; Xu L; Xiao W; Mao H; Chen W
    Int Urol Nephrol; 2022 Nov; 54(11):2959-2967. PubMed ID: 35581444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
    Li Y; Lu H; Guo J; Zhang M; Zheng H; Liu Y; Liu W
    Ann Med; 2023 Dec; 55(1):2215542. PubMed ID: 37246850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.